ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Recruiting
Observational Study
Depressed Mood
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 5,000 (estimated)
- Sponsor
- Salma Health, Inc. · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will evaluate the feasibility and clinical utility of developing predictive models of treatment response for patients with depressed mood using multimodal clinical data collected in real-world clinical settings. The study will examine outcomes among patients treated with interventions including esketamine, conventional transcranial magnetic stimulation (TMS), or Stanford Accelerated Int…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adults (≥18 years) of any gender identity presenting for care with a depressed mood.
* Prescribed treatment with esketamine, conventional TMS, or SAINT as part of standard clinical care.
* Able to provide informed consent and comply with all study requirements.
Exclusion Crit…
Contacts
No contact information available.